With a liquidity drought fading, investors can return to the more normal task of building private market portfolios designed ...

Federal Reserve Chairman Jerome Powell said Wednesday he supports a change to bank capital rules that has been on the industry's wish list At the moment, the Fed's "supplementary leverage ratio" ...

Investment barriers have long been taboo among U.S. policymakers, for fear that a mere mention could spook the world's ...

Prospect Capital's portfolio continues to show weakness in a high interest rate environment. Read why I downgrade PSEC stock ...

While there will always be an appetite for strong, growth-oriented companies, startups may have to pivot from growth at any cost to profitable growth as Trump’s tariffs continue to roil markets, ...

Follow all the latest U.S. market action for Tuesday here as investors get ready for testimony from Fed Chair Jerome Powell, ...

We recently published a list of 10 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where ...

The Capital Markets Authority (CMA) of Kenya has announced multiple managerial job openings, inviting qualified professionals ...

Surprisingly strong U.S. inflation in January stoked investor fears that a heating economy and looming tariffs could corner ...

The CEO of Kronos Capital said the firm is withdrawing its current application for a tall building at 200 Market Street. Nash Bowen said the firm will be in talks with the Cherry Street Townhomes in ...

Talk to Toronto entrepreneurs and investors, and they agree that homegrown tech talent, being located in the nation’s ...

Jasper Therapeutics, Inc. (JSPR) stock has hit a 52-week low, trading at $4.99, down 21% in the past week alone. According to InvestingPro analysis, the stock's RSI indicates oversold conditions, with ...